A quick review of the available AE data from studies examined for this review show a similar pattern (data not shown).
there was generally insufficient information included within the publications examined to allow for a thorough assessment of the risk for treatment emergent suicidal to occur with these products.
Whether this was because events did not occur that were suggestive of emergent suicidal, or because such events, if they occurred, were simply considered a symptom of the underlying disorder rather than an AE, is not clear
the latter scenario is conceivable, given that the majority of these studies were conducted well before the issue of treatment-emergent suicidal became widely recognized.